throwing up from tirzepatide Side Effects. What You Shouldn't Ignore Very sick, is this common?

ABSTRACT In the context of a global shortage of glucagon-like peptide-1 (GLP-1) receptor agonists, we assessed the impact of discontinuing dulaglutide on metabolic control in individuals with type 2 diabetes

A screenshot from Hims & Hers' website

In a 40-year-old woman taking tirzepatide (Mounjaro) 2.5 mg weekly who received her injection on day 4 of a recent flu and now has nausea, vomiting, constipation and cannot retain oral intake, should the tirzepatide be held and how should her symptoms be managed?

Due to this high aerobic demand, the generation of high amounts of ROS and other oxidative by-products is unavoidable (Halliwell, 2006)

Retrieved from Premera Blue Cross